Quick Answer
BIOMARIN PHARMACEUTICAL INC reported Common Stock Shares Outstanding of 192.30 million shares for the year ending 2025.
- BIOMARIN PHARMACEUTICAL INC showed an increase of +0.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BIOMARIN PHARMACEUTICAL INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), BIOMARIN PHARMACEUTICAL INC's Common Stock Shares Outstanding has grown by 90.5%.
- Historical annual values: Fiscal year 2025: 192.30 million shares | Fiscal year 2024: 190.76 million shares | Fiscal year 2023: 188.60 million shares | Fiscal year 2022: 186.25 million shares | Fiscal year 2021: 183.91 million shares | Fiscal year 2020: 181.74 million shares | Fiscal year 2019: 179.84 million shares | Fiscal year 2018: 178.25 million shares | Fiscal year 2017: 175.84 million shares | Fiscal year 2016: 172.65 million shares | Fiscal year 2015: 161.53 million shares | Fiscal year 2014: 149.09 million shares | Fiscal year 2013: 143.46 million shares | Fiscal year 2012: 125.81 million shares | Fiscal year 2011: 114.79 million shares | Fiscal year 2010: 110.63 million shares | Fiscal year 2009: 100.96 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: